Sort
82,697 grants matching “vaccine development”
Development of an Effector-Memory T Cell AIDS Vaccine
$3,377,368Louis J. Picker · Oregon Health & Science University · P01 · FY2014 · AI
A Genomics Based Investigation of the Determinants of Polymicrobial Infectious Disease Outcomes
$3,375,081David A Rasko · University Of Maryland Baltimore · U19 · FY2023 · AI
Molecular Mechanisms of Filoviral-host Interactions
$3,374,001Gaya K. Amarasinghe · Washington University · P01 · FY2025 · AI
Molecular Mechanisms of Filoviral-host Interactions
$3,374,001Gaya K. Amarasinghe · Washington University · P01 · FY2024 · AI
Durable Antibody Mediated Protection Against HIV
$3,373,790Robert C Gallo · University Of Maryland Baltimore · P01 · FY2018 · AI
Alphavirus Replicon Vaccines to Encephalitis Viruses
$3,373,441Alphavax Human Vaccines, Inc. · U01 · FY2005 · AI
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$3,372,423Stephen A Spector · University Of California, San Diego · UM1 · FY2019 · AI
Mechanisms of protective immunity induced by live attenuated SIV vaccines
$3,370,567R. Paul Johnson · Harvard Medical School · P01 · FY2010 · AI
Center for AIDS Research
$3,370,245David Mitchell Smith · University Of California, San Diego · P30 · FY2018 · AI
University of North Carolina AIDS Clinical Trials Unit (UNC ACTU)
$3,370,206Joseph J. Eron · Univ Of North Carolina Chapel Hill · U01 · FY2009 · AI
Increasing financial and health equity among low income black youth and young adults
$3,369,104Sheri Ann Lippman · University Of California, San Francisco · U01 · FY2021 · OD
Center for AIDS Research
$3,368,977Ronald G Collman · University Of Pennsylvania · P30 · FY2016 · AI
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
$3,368,475Martin Cheever · Fred Hutchinson Cancer Research Center · U01 · FY2012 · CA
PItt-Ohio State-Georgetown Clinical Trials Unit
$3,366,355John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2019 · AI
New England Regional Center of Excellence in Biodefense and Emerging Infectious D
$3,365,340Dennis L. Kasper · Harvard Medical School · U54 · FY2009 · AI
Malaria Vaccine: Pfs25-rEPA
$3,362,281Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.
$3,361,716Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2023 · CA
Orthopox immunization in patients with cancer or eczema
$3,360,940Dana-Farber Cancer Institute · U19 · FY2004 · AI
cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine
$3,358,279Thomas Hassell · International Aids Vaccine Initiative · N01 · FY2025 · AI
Immunobiology of Peanut Allergy and Its Treatment: A Prototype
$3,357,049Hugh Sampson · Icahn School Of Medicine At Mount Sinai · U19 · FY2006 · AI
Molecular Mechanisms of Filoviral-host Interactions
$3,354,992Gaya K. Amarasinghe · Washington University · P01 · FY2023 · AI
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT)
$3,354,504Abhijit Prakash Limaye · University Of Washington · U01 · FY2022 · AI
FLSC - Vaccine Branch HIV Vaccine Primate Study
$3,353,372Mary Custer · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
RCMI Center for Health Disparities Research
$3,352,501Deepak Kumar · North Carolina Central University · U54 · FY2023 · MD
HIV VACCINE DESIGN AND DEVELOPMENT TEAMS PART A - PREVENTATIVE VACCINES
$3,352,012Hussein Naim · · N01 · FY2007 · AI